“SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS”, Int. Res. J. Pharm., vol. 17, no. 9, pp. 11–17, Sep. 2026, doi: 10.56802/cyzkpf46.